 |
Harbour BioMed
Last updated: April 19, 2024
Jingsong Wang, CEO
Country: China | Funding: $312.8M (+)
Website: http://www.harbourbiomed.com/en/
Harbour BioMed is a global biopharmaceutical company developing innovative therapeutics in the field of immuno-oncology and inflammatory diseases.
Website: http://www.harbourbiomed.com/en/
Harbour BioMed is a global biopharmaceutical company developing innovative therapeutics in the field of immuno-oncology and inflammatory diseases.
